PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27281349-5	2016	Budesonide suppressed secreted chemokines IL-8 and CCL2 (MCP-1) within 4 hours, reaching a 90% decrease at 12 hours, which was fully reversed 72 hours after removal of the steroid.	Budesonide	0-10	C-C motif chemokine ligand 2	Homo sapiens	51-55	
27281349-5	2016	Budesonide suppressed secreted chemokines IL-8 and CCL2 (MCP-1) within 4 hours, reaching a 90% decrease at 12 hours, which was fully reversed 72 hours after removal of the steroid.	Budesonide	0-10	C-C motif chemokine ligand 2	Homo sapiens	57-62	
21148795-3	2011	Cell treatment with the potent GC budesonide accelerated the decay of CCL2 mRNA (t(1/2) = 8 +- 1 min versus 62 +- 17 min in DMSO-treated cells) and CCL7 mRNA (t(1/2) = 15 +- 4 min versus 114 +- 37 min), but not that of CCL5 mRNA (t(1/2)=231 +- 8 min versus 266 +- 5 min) in the BEAS-2B cell line.	Budesonide	34-44	C-C motif chemokine ligand 2	Homo sapiens	70-74	
16266385-6	2005	A single dose of nasal budesonide caused a decrease in symptoms (P < 0.05) and nasal eosinophils (P < 0.05) with selective abrogation of IL-5 and IL-13 responses (P < 0.05), but a lack of effect on levels of eotaxin, RANTES, IL-8 and MCP-1.	Budesonide	23-33	C-C motif chemokine ligand 2	Homo sapiens	243-248